177 related articles for article (PubMed ID: 34831367)
1. Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells.
Vella V; Giuliano M; La Ferlita A; Pellegrino M; Gaudenzi G; Alaimo S; Massimino M; Pulvirenti A; Dicitore A; Vigneri P; Vitale G; Malaguarnera R; Morrione A; Sims AH; Ferro A; Maggiolini M; Lappano R; De Francesco EM; Belfiore A
Cells; 2021 Nov; 10(11):. PubMed ID: 34831367
[TBL] [Abstract][Full Text] [Related]
2. The role of WT1 isoforms in vasculogenic mimicry and metastatic potential of human triple negative breast cancer cells.
Bissanum R; Lirdprapamongkol K; Svasti J; Navakanitworakul R; Kanokwiroon K
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):256-262. PubMed ID: 29024629
[TBL] [Abstract][Full Text] [Related]
3. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
5. Comparative use of CRISPR and RNAi to modulate integrin α3β1 in triple negative breast cancer cells reveals that some pro-invasive/pro-metastatic α3β1 functions are independent of global regulation of the transcriptome.
Kenney J; Ndoye A; Lamar JM; DiPersio CM
PLoS One; 2021; 16(7):e0254714. PubMed ID: 34270616
[TBL] [Abstract][Full Text] [Related]
6. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
7. Genomic regulation of invasion by STAT3 in triple negative breast cancer.
McDaniel JM; Varley KE; Gertz J; Savic DS; Roberts BS; Bailey SK; Shevde LA; Ramaker RC; Lasseigne BN; Kirby MK; Newberry KM; Partridge EC; Jones AL; Boone B; Levy SE; Oliver PG; Sexton KC; Grizzle WE; Forero A; Buchsbaum DJ; Cooper SJ; Myers RM
Oncotarget; 2017 Jan; 8(5):8226-8238. PubMed ID: 28030809
[TBL] [Abstract][Full Text] [Related]
8. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
9. CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis.
Wu J; Li L; Liu J; Wang Y; Wang Z; Wang Y; Liu W; Zhou Z; Chen C; Liu R; Yang R
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):835-842. PubMed ID: 30032244
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑126‑3p inhibits the proliferation, migration, invasion, and angiogenesis of triple‑negative breast cancer cells by targeting RGS3.
Hong Z; Hong C; Ma B; Wang Q; Zhang X; Li L; Wang C; Chen D
Oncol Rep; 2019 Oct; 42(4):1569-1579. PubMed ID: 31364749
[TBL] [Abstract][Full Text] [Related]
11. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract][Full Text] [Related]
12. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
[TBL] [Abstract][Full Text] [Related]
13. Constructing a novel prognostic model for triple-negative breast cancer based on genes associated with vasculogenic mimicry.
Ren Y; Feng L; Tan Z; Zhou F; Liu S
Aging (Albany NY); 2024 May; 16(9):8086-8109. PubMed ID: 38728245
[TBL] [Abstract][Full Text] [Related]
14. Functional Characterization of lncRNA152 as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers.
Kim DS; Camacho CV; Setlem R; Kim K; Malladi S; Hou TY; Nandu T; Gadad SS; Kraus WL
Mol Cancer Res; 2022 Nov; 20(11):1623-1635. PubMed ID: 35997635
[TBL] [Abstract][Full Text] [Related]
15. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
16. Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation.
Vella V; Nicolosi ML; Giuliano M; Morrione A; Malaguarnera R; Belfiore A
Cells; 2019 Sep; 8(9):. PubMed ID: 31480557
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8.
Zeng X; Ma X; Guo H; Wei L; Zhang Y; Sun C; Han N; Sun S; Zhang N
Bioengineered; 2021 Dec; 12(2):10126-10135. PubMed ID: 34978519
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of the Fetal Insulin Receptor in Hormone-refractory Breast Cancer.
Mathur T; Yee D
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34304271
[TBL] [Abstract][Full Text] [Related]
19. Insulin Receptor Isoforms in Cancer.
Vella V; Milluzzo A; Scalisi NM; Vigneri P; Sciacca L
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453495
[TBL] [Abstract][Full Text] [Related]
20. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells.
Yue CH; Liu JY; Chi CS; Hu CW; Tan KT; Huang FM; Pan YR; Lin KI; Lee CJ
Anticancer Res; 2019 Aug; 39(8):4149-4164. PubMed ID: 31366500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
